{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:53:58Z","timestamp":1777416838493,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T00:00:00Z","timestamp":1533772800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12906-018-2304-8","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T14:30:08Z","timestamp":1533825008000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["The management strategies of cancer-associated anorexia: a critical appraisal of systematic reviews"],"prefix":"10.1186","volume":"18","author":[{"given":"Fangyuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aomei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinghui","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9044-7476","authenticated-orcid":false,"given":"Wanmin","family":"Qiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,9]]},"reference":[{"issue":"4","key":"2304_CR1","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","volume":"3","author":"C Fitzmaurice","year":"2017","unstructured":"Fitzmaurice C, Allen C, Barber RM, et al. Global, regional, and National Cancer Incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 Cancer groups, 1990 to 2015. JAMA Oncol. 2017;3(4):524\u201348. https:\/\/doi.org\/10.1001\/jamaoncol.2016.%205688 .","journal-title":"JAMA Oncol"},{"issue":"24","key":"2304_CR2","doi-asserted-by":"publisher","first-page":"5767","DOI":"10.1002\/cncr.25681","volume":"116","author":"L Barbera","year":"2010","unstructured":"Barbera L, Seow H, Howell D, et al. Symptom burden and performance status in a population-based cohort of ambulatory cancer patients. Cancer. 2010;116(24):5767\u201376.","journal-title":"Cancer"},{"issue":"1","key":"2304_CR3","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jpainsymman.2013.02.016","volume":"47","author":"LA Van","year":"2014","unstructured":"Van LA, Velghe A, Van HA, et al. Prevalence of symptoms in older cancer patients receiving palliative care: a systematic review and meta-analysis. J Pain Symptom Manag. 2014;47(1):90\u2013104.","journal-title":"J Pain Symptom Manag"},{"issue":"8","key":"2304_CR4","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1089\/jpm.2011.0086","volume":"14","author":"JM Giesinger","year":"2011","unstructured":"Giesinger JM, Wintner LM, Oberguggenberger AS, et al. Quality of life trajectory in patients with advanced cancer during the last year of life. J Palliat Med. 2011;14(8):904\u201312.","journal-title":"J Palliat Med"},{"issue":"7","key":"2304_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jnci\/dju129","volume":"106","author":"BB Reeve","year":"2014","unstructured":"Reeve BB, Mitchell SA, Dueck AC, et al. Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. J Natl Cancer Inst. 2014;106(7):1\u20138.","journal-title":"J Natl Cancer Inst"},{"issue":"33","key":"2304_CR6","doi-asserted-by":"publisher","first-page":"8500","DOI":"10.1200\/JCO.2005.01.8010","volume":"23","author":"T Yavuzsen","year":"2005","unstructured":"Yavuzsen T, Davis MP, Walsh D, et al. Systematic review of the treatment of cancer-associated anorexia and weight loss. J Clin Oncol. 2005;23(33):8500\u201311.","journal-title":"J Clin Oncol"},{"key":"2304_CR7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.critrevonc.2015.12.008","volume":"99","author":"R Tarricone","year":"2016","unstructured":"Tarricone R, Ricca G, Nyanzi WB, et al. Impact of cancer anorexia-cachexia syndrome on health-related quality of life and resource utilisation: a systematic review. Crit Rev Oncol Hematol. 2016;99:49\u201362.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"2304_CR8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/jcsm.12010","volume":"6","author":"C Cooper","year":"2015","unstructured":"Cooper C, Burden ST, Cheng H, et al. Understanding and managing cancer-related weight loss and anorexia: insights from a systematic review of qualitative research. J Cachexia Sarcopenia Muscle. 2015;6(1):99\u2013111.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"2304_CR9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.critrevonc.2012.02.011","volume":"84","author":"M Trajkovic-Vidakovic","year":"2012","unstructured":"Trajkovic-Vidakovic M, de Graeff A, Voest EE, et al. Symptoms tell it all: a systematic review of the value of symptom assessment to predict survival in advanced cancer patients. Crit Rev Oncol Hematol. 2012;84(1):130\u201348.","journal-title":"Crit Rev Oncol Hematol"},{"key":"2304_CR10","doi-asserted-by":"publisher","first-page":"j4008","DOI":"10.1136\/bmj.j4008","volume":"358","author":"BJ Shea","year":"2017","unstructured":"Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008.","journal-title":"BMJ"},{"key":"2304_CR11","first-page":"84","volume":"4","author":"J Kung","year":"2010","unstructured":"Kung J, Chiappelli F, Cajulis OO, et al. From systematic reviews to clinical recommendations for evidence-based health care: validation of revised assessment of multiple systematic reviews (R-AMSTAR) for grading of clinical relevance. Open Dent J. 2010;4:84\u201391.","journal-title":"Open Dent J"},{"issue":"64","key":"2304_CR12","first-page":"1","volume":"15","author":"H Pinnock","year":"2017","unstructured":"Pinnock H, Parke HL, Panagioti M, et al. Systematic meta-review of supported self-management for asthma: a healthcare perspective. BMC Med. 2017;15(64):1\u201332.","journal-title":"BMC Med"},{"issue":"9","key":"2304_CR13","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1007\/s00167-014-3151-x","volume":"23","author":"M Kowalczuk","year":"2015","unstructured":"Kowalczuk M, Adamich J, Simunovic N, et al. Methodological quality of systematic reviews addressing femoroacetabular impingement. Knee Surg Sports Traumatol Arthrosc. 2015;23(9):2583\u20139.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"issue":"3","key":"2304_CR14","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1023\/A:1011156811739","volume":"12","author":"M Maltoni","year":"2001","unstructured":"Maltoni M, Nanni O, Scarpi E, et al. High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: a systematic review of randomised clinical trials. Ann Oncol. 2001;12(3):289\u2013300.","journal-title":"Ann Oncol"},{"issue":"4","key":"2304_CR15","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jpainsymman.2003.09.007","volume":"27","author":"LA Pascual","year":"2004","unstructured":"Pascual LA, Roque IFM, Urrutia CG, et al. Systematic review of megestrol acetate in the treatment of anorexia-cachexia syndrome. J Pain Symptom Manag. 2004;27(4):360\u20139.","journal-title":"J Pain Symptom Manag"},{"key":"2304_CR16","volume":"2","author":"EG Berenstein","year":"2005","unstructured":"Berenstein EG, Ortiz Z. Megestrol acetate for the treatment of anorexia-cachexia syndrome. Cochrane Database Syst Rev. 2005;2:CD004310.","journal-title":"Cochrane Database Syst Rev"},{"key":"2304_CR17","volume":"1","author":"D Ann","year":"2007","unstructured":"Ann D, Chris B, Dean TP, et al. Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia. Cochrane Database Syst Rev. 2007;1:CD004597.","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"2304_CR18","doi-asserted-by":"crossref","first-page":"636","DOI":"10.20452\/pamw.510","volume":"118","author":"L Wiktoria","year":"2008","unstructured":"Wiktoria L, Malgorzata B, Roman J, et al. Effects of megestrol acetate in patients with cancer anorexia-cachexia syndrome: a systematic review and meta-analysis. Pol Arch Med Wewn. 2008;118(11):636\u201344.","journal-title":"Pol Arch Med Wewn"},{"issue":"5","key":"2304_CR19","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/jnci\/djr556","volume":"104","author":"C Baldwin","year":"2012","unstructured":"Baldwin C, Spiro A, Ahern R, et al. Oral nutritional interventions in malnourished patients with cancer: a systematic review and meta-analysis. J Natl Cancer Inst. 2012;104(5):371\u201385.","journal-title":"J Natl Cancer Inst"},{"key":"2304_CR20","volume":"4","author":"J Reid","year":"2012","unstructured":"Reid J, Mills M, Cantwell M, et al. Thalidomide for managing cancer cachexia. Cochrane Database Syst Rev. 2012;4:CD008664.","journal-title":"Cochrane Database Syst Rev"},{"key":"2304_CR21","volume":"3","author":"GV Ruiz","year":"2013","unstructured":"Ruiz GV, Lopez-Briz E, Carbonell SR, et al. Megestrol acetate for treatment of anorexia-cachexia syndrome. Cochrane Database Syst Rev. 2013;3:CD004310.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"2304_CR22","doi-asserted-by":"publisher","first-page":"e321","DOI":"10.3747\/co.20.1431","volume":"20","author":"C Payne","year":"2013","unstructured":"Payne C, Larkin PJ, McIlfatrick S, et al. Exercise and nutrition interventions in advanced lung cancer: a systematic review. Curr Oncol. 2013;20(4):e321\u201337.","journal-title":"Curr Oncol"},{"issue":"4","key":"2304_CR23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1177\/0269216312441382","volume":"27","author":"J Reid","year":"2013","unstructured":"Reid J, Hughes CM, Murray LJ, et al. Cantwell MM. Non-steroidal anti-inflammatory drugs for the treatment of cancer cachexia: a systematic review. Palliative Med. 2013;27(4):295\u2013303.","journal-title":"Palliative Med"},{"issue":"1","key":"2304_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3109\/0284186X.2012.724536","volume":"52","author":"TS Solheim","year":"2013","unstructured":"Solheim TS, Fearon KC, Blum D, et al. Non-steroidal anti-inflammatory treatment in cancer cachexia: a systematic literature review. Acta Oncol. 2013;52(1):6\u201317.","journal-title":"Acta Oncol"},{"issue":"4","key":"2304_CR25","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1089\/jpm.2013.0324","volume":"17","author":"S Miller","year":"2014","unstructured":"Miller S, McNutt L, McCann MA, et al. Use of corticosteroids for anorexia in palliative medicine: a systematic review. J Palliat Med. 2014;17(4):482\u20135.","journal-title":"J Palliat Med"},{"issue":"7","key":"2304_CR26","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002793","volume":"95","author":"VC Chung","year":"2016","unstructured":"Chung VC, Wu X, Lu P, et al. Chinese herbal medicine for symptom Management in Cancer Palliative Care: systematic review and Meta-analysis. Medicine (Baltimore). 2016;95(7):e2793.","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"2304_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002901","volume":"95","author":"CHY Lau","year":"2016","unstructured":"Lau CHY, Wu X, Chung VCH, et al. Acupuncture and related therapies for symptom management in palliative cancer care: systematic review and meta-analysis. Medicine (Baltimore). 2016;95(9):e2901.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"2304_CR28","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1007\/s00520-016-3560-0","volume":"25","author":"Y Bai","year":"2017","unstructured":"Bai Y, Hu Y, Zhao Y, et al. Anamorelin for cancer anorexia-cachexia syndrome: a systematic review and meta-analysis. Support Care Cancer. 2017;25(5):1651\u20139.","journal-title":"Support Care Cancer"},{"issue":"1","key":"2304_CR29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/jcsm.12127","volume":"8","author":"Mochamat","year":"2017","unstructured":"Mochamat, Cuhls H, Marinova M, et al. A systematic review on the role of vitamins, minerals, proteins, and other supplements for the treatment of cachexia in cancer: a European palliative care research Centre cachexia project. J Cachexia Sarcopenia Muscle. 2017;8(1):25\u201339.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"2304_CR30","first-page":"28","volume":"24","author":"S Li","year":"2017","unstructured":"Li S, Ma H, Li S. Review and Meta-analysis of the \u03c9-3 polyunsaturated fatly acid for cancer cechexia treatment. Changnei Yu Changwai Yingyang. 2017;24(1):28\u201332.","journal-title":"Changnei Yu Changwai Yingyang"},{"issue":"3","key":"2304_CR31","first-page":"1","volume":"2","author":"D Moher","year":"2002","unstructured":"Moher D, Soeken K, Sampson M, et al. Assessing the quality of reports of systematic reviews in pediatric complementary and alternative medicine. BMC Pediatr. 2002;2(3):1\u20138.","journal-title":"BMC Pediatr"},{"issue":"7234","key":"2304_CR32","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1136\/bmj.320.7234.537","volume":"320","author":"AR Jadad","year":"2000","unstructured":"Jadad AR, Moher M, Browman GP, et al. Systematic reviews and meta-analyses on treatment of asthma: critical evaluation. BMJ. 2000;320(7234):537\u201340.","journal-title":"BMJ"},{"issue":"10","key":"2304_CR33","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.jclinepi.2008.10.009","volume":"62","author":"BJ Shea","year":"2009","unstructured":"Shea BJ, Hamel C, Wells GA, et al. AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews. J Clin Epidemiol. 2009;62(10):1013\u201320.","journal-title":"J Clin Epidemiol"},{"key":"2304_CR34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2288-7-10","volume":"7","author":"BJ Shea","year":"2007","unstructured":"Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 2007;7:10.","journal-title":"BMC Med Res Methodol"},{"key":"2304_CR35","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13643-016-0237-1","volume":"5","author":"BU Burda","year":"2016","unstructured":"Burda BU, Holmer HK, Norris SL. Limitations of a measurement tool to assess systematic reviews (AMSTAR) and suggestions for improvement. Syst Rev. 2016;5:58.","journal-title":"Syst Rev"},{"issue":"1","key":"2304_CR36","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12874-016-0183-6","volume":"16","author":"U Wegewitz","year":"2016","unstructured":"Wegewitz U, Weikert B, Fishta A, et al. Resuming the discussion of AMSTAR: what can (should) be made better? BMC Med Res Methodol. 2016;16(1):111.","journal-title":"BMC Med Res Methodol"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-018-2304-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12906-018-2304-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-018-2304-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T08:14:21Z","timestamp":1751789661000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-018-2304-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,9]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2304"],"URL":"https:\/\/doi.org\/10.1186\/s12906-018-2304-8","relation":{},"ISSN":["1472-6882"],"issn-type":[{"value":"1472-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,9]]},"assertion":[{"value":"25 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable: a critical review of systematic reviews.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable: no individual person\u2019s data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"236"}}